CardioComm Solutions (EKG.V) Stock Price
CardioComm Solutions Price
Revenue at CardioComm Solutions has contracted by 3.4% per year over the past 19 years to 526,700.00 CAD. CardioComm Solutions's net margin stands at -36.9%, down from -7.6% several years earlier. The stock trades about 12,700% above its 52-week low.
CardioComm Solutions stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of CardioComm Solutions over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CardioComm Solutions stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CardioComm Solutions's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | CardioComm Solutions Price |
|---|---|
| 9/25/2026 | 0.01 CAD |
| 9/24/2026 | 0.01 CAD |
| 9/23/2026 | 0.01 CAD |
| 9/22/2026 | 0.01 CAD |
| 9/21/2026 | 0.01 CAD |
| 9/18/2026 | 0.01 CAD |
| 9/17/2026 | 0.00 CAD |
| 9/16/2026 | 0.01 CAD |
| 9/15/2026 | 0.01 CAD |
| 9/14/2026 | 0.01 CAD |
| 9/11/2026 | 0.00 CAD |
| 9/10/2026 | 0.01 CAD |
| 9/9/2026 | 0.01 CAD |
| 9/8/2026 | 0.01 CAD |
| 9/4/2026 | 0.00 CAD |
| 9/3/2026 | 0.01 CAD |
| 9/2/2026 | 0.01 CAD |
| 9/1/2026 | 0.01 CAD |
| 8/31/2026 | 0.01 CAD |
| 8/28/2026 | 0.01 CAD |
| 8/27/2026 | 0.01 CAD |
| 8/26/2026 | 0.01 CAD |
| 8/25/2026 | 0.01 CAD |
| 8/24/2026 | 0.01 CAD |
| 8/21/2026 | 0.01 CAD |
| 8/20/2026 | 0.01 CAD |
| 8/19/2026 | 0.01 CAD |
| 8/18/2026 | 0.01 CAD |
| 8/17/2026 | 0.01 CAD |
| 8/14/2026 | 0.01 CAD |
CardioComm Solutions Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
CardioComm Solutions Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM CAD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEk CAD |
| EBITM CAD |
| EBIT MARGIN% |
| NET INCOMEM CAD |
| NET INCOME GROWTH% |
| SHARESM |
| 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 1.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | – | – | – | – | – | – |
| – | – | 100.00 | -50.00 | – | – | – | – | – | – | – | – | – | – | – | – |
| 100.00 | 100.00 | 50.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | – | – | – | – | – | – |
| 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 | 1,000.00 |
| -1.00 | – | – | -3.00 | -1.00 | – | – | – | – | – | – | – | – | – | – | – |
| -100.00 | – | – | -300.00 | -100.00 | – | – | – | – | – | – | – | – | – | – | – |
| -1.00 | – | – | -3.00 | -1.00 | – | – | – | – | – | -1.00 | – | – | – | – | – |
| – | – | – | – | -66.67 | – | – | – | – | – | – | – | – | – | – | – |
| 45.74 | 60.13 | 75.65 | 91.66 | 100.26 | 106.77 | 112.16 | 115.86 | 135.04 | 137.22 | 139.52 | 141.44 | 149.15 | 150.82 | 151.15 | 171.20 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales CardioComm Solutions generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CardioComm Solutions retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CardioComm Solutions's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares CardioComm Solutions has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CardioComm Solutions's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
CardioComm Solutions stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
CardioComm Solutions Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
CardioComm Solutions business model & stock analysis
CardioComm Solutions SWOT Analysis
Strengths
CardioComm Solutions Inc has several strengths that contribute to its success in the market. These include:
- Strong product line: CardioComm offers a range of innovative and reliable healthcare solutions.
- Market leadership: The company has established itself as a leader in the electrocardiogram (ECG) management market.
- Advanced technology: CardioComm's solutions leverage cutting-edge technology, ensuring accuracy and efficiency.
- Strong customer base: The company has built a loyal customer base, including healthcare providers and institutions.
- Experienced management team: CardioComm is led by a team of industry experts with extensive knowledge and experience.
Weaknesses
Despite its strengths, CardioComm Solutions Inc also faces certain weaknesses that it needs to address. These weaknesses include:
- Limited market presence: The company may face challenges in expanding its market reach and penetrating new regions.
- Dependence on key customers: CardioComm relies heavily on a few major customers, which poses a risk to its revenue stream.
- High product costs: The advanced technology used in CardioComm's solutions may make them expensive for some potential customers.
Opportunities
CardioComm Solutions Inc can capitalize on several opportunities to further grow and enhance its market position. These opportunities include:
- Expanding into new markets: The company can explore untapped markets and expand its customer base globally.
- Partnerships and collaborations: CardioComm can establish strategic partnerships with healthcare institutions to accelerate adoption of its solutions.
- Advancements in telemedicine: The growing trend of telemedicine presents an opportunity for CardioComm to offer remote heart monitoring solutions.
- Increasing healthcare awareness: The increasing focus on preventive healthcare creates a demand for advanced cardiac monitoring solutions.
Threats
Despite the opportunities, CardioComm Solutions Inc also faces certain threats that could potentially hinder its growth. These threats include:
- Intense competition: The market for ECG management solutions is highly competitive, with several established players.
- Regulatory challenges: Changing regulations and compliance requirements can pose challenges for CardioComm's products and services.
- Technological advancements: Rapid advancements in technology may render CardioComm's existing solutions obsolete if not adapted timely.
- Economic downturn: A recession or economic downturn can lead to reduced healthcare spending, impacting CardioComm's sales.
CardioComm Solutions Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
CardioComm Solutions historical P/E ratio, EBIT multiple, and P/S ratio
CardioComm Solutions annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down CardioComm Solutions's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in CardioComm Solutions's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare CardioComm Solutions's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
CardioComm Solutions shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
CardioComm Solutions stock splits
Since 1998, a total of 0.06666666666666667 shares have been converted from one CardioComm Solutions share.
CardioComm Solutions shareholder structure
| % | Name |
|---|---|
22.67609% | |
22.11540% | |
8.50242% | |
1.08048% | |
0.38551% |
CardioComm Solutions Executives and Management Board
7 members · 14 % women
Mr. Etienne Grima
Chief Executive Officer, Corporate Secretary, Director · since 2006
190,487.00 CAD
Management
Ms. Josee Bertrand
Chief Financial Officer
Board of Directors
Mr. Robert Caines
Independent Chairman of the Board
Mr. Steven Benyo
Independent Director
Dr. John Foote
Independent Director
Mr. Simi Grosman
Independent Director
Mr. David Newman
Independent Director
Frequently asked questions about CardioComm Solutions
The business model of CardioComm Solutions Inc focuses on providing innovative, web-based telemedicine and patient monitoring solutions. With a strong emphasis on cardiac healthcare, the company offers a range of software tools and services that enable remote monitoring, analysis, and reporting of heart-related medical data. By leveraging advanced technology and expertise in electrocardiography (ECG), CardioComm Solutions aims to enhance patient care, streamline workflow efficiency, and facilitate better communication between healthcare professionals, patients, and caregivers. The company continues to develop and optimize its solutions to meet the evolving needs of the healthcare industry, promoting improved outcomes and increased accessibility to cardiac diagnostics and monitoring.
CardioComm Solutions Inc is primarily active in the healthcare technology industry.
The main competitors of CardioComm Solutions Inc in the market include companies such as Medtronic, Philips Healthcare, and AliveCor.
CardioComm Solutions Inc., a leading provider of digital health software solutions, has an impressive history and background. Established in 1994, the company has been at the forefront of advancing remote monitoring technologies for cardiovascular health. With their flagship product, the GlobalCardio™ ECG device, CardioComm Solutions revolutionized telemedicine by enabling accurate, real-time transmission of patient ECG data to healthcare professionals. Over the years, the company has continually evolved, introducing innovative products and solutions designed to enhance patient care, including the FDA-cleared CardioComm HeartCheck™ ECG pen. Today, CardioComm Solutions Inc. remains dedicated to leveraging technology to improve cardiovascular diagnostics and monitoring, making them a trusted name in the digital health industry.
CardioComm Solutions Inc has achieved several significant milestones throughout its history. The company has successfully developed and commercialized innovative medical software solutions focused on the diagnosis and management of cardiac patients. Some key achievements include the clearance and approval of their ECG management software by regulatory authorities like the FDA and Health Canada. CardioComm Solutions Inc has also established strategic partnerships with renowned healthcare organizations and industry leaders, expanding their global reach and market presence. These milestones highlight the company's commitment to advancing cardiovascular healthcare through cutting-edge technology and their strong commitment to delivering high-quality solutions to healthcare practitioners and patients worldwide.
CardioComm Solutions Inc is primarily present in several countries and regions. The company's operations extend to North America, including the United States and Canada. With a focus on providing innovative cardiac monitoring solutions, CardioComm Solutions Inc also serves customers in Europe, including the United Kingdom, Germany, France, and Italy. Additionally, the company's presence reaches Asia, catering to markets in Japan and China. With its global footprint, CardioComm Solutions Inc aims to deliver its cutting-edge technologies and services to healthcare professionals and patients worldwide.
CardioComm Solutions Inc represents a strong commitment to innovation, technological advancements, and quality healthcare solutions. With a focus on developing and marketing high-quality electrocardiogram (ECG) software and devices, the company aims to improve patient care and outcomes. CardioComm Solutions Inc prioritizes excellence in product development, ensuring their solutions meet stringent medical standards. The company's corporate philosophy centers around providing healthcare providers with reliable and user-friendly tools to enhance the diagnosis and management of cardiac conditions. By embracing cutting-edge technologies and a patient-centric approach, CardioComm Solutions Inc strives to be a leader in the field of cardiac care.
Converted at the current exchange rate, the CardioComm Solutions share trades at 0.01 EUR (0.01 CAD).
CardioComm Solutions Inc. is a company that specializes in innovative solutions in the field of telemedicine and telecardiological monitoring. The company offers a wide range of products and services to improve cardiac diagnosis, monitoring, and care. The business model of CardioComm Solutions Inc. is based on several divisions, including the development and marketing of software, hardware, and cloud-based solutions. The company's main products include Smart ECG and GEMS Home System, which can be used to monitor heart rate, ECG, and other cardiac parameters. These products are capable of collecting and analyzing real-time data, enabling remote patient monitoring, particularly in rural and remote areas or for patients with special needs. Another important component of CardioComm Solutions Inc.'s business model is the sale of license and service agreements. This includes rights to patented technologies, as well as physician-patient communication and other security requirements. In collaboration with medical facilities, health systems, private clinics, and companies, the company offers a wide range of services including telemedicine needs analysis and consultation, installation, and support. To succeed in the market, CardioComm Solutions Inc. relies on close collaboration with medical facilities, research institutions, and universities. It constantly works to improve its products and services and drive application-oriented innovations. The company takes pride in its ability to analyze complex data in real-time and provide medically relevant information to enable doctors and medical personnel to achieve the best possible diagnosis and treatment outcomes. As a company, CardioComm Solutions Inc. adopts a future-oriented strategy characterized by adherence to high standards, close collaboration and partnership, and continuous investment in innovative technologies and the ongoing improvement of products and services. The company is headquartered in Toronto, Canada, and operates worldwide. Customers can rely on reliable and professional support. A tailored solution is always developed to ensure the best possible outcome. In summary, the business model of CardioComm Solutions Inc. is characterized by the development and marketing of telemedicine monitoring solutions, such as Smart ECG and GEMS Home System, which are used to monitor the patient's cardiac parameters. The company also offers license and service contracts, including telemedicine needs analysis and consultation, installation, and support. The company always prioritizes innovation and collaboration and is ready to quickly and flexibly respond to new requirements to meet customer needs.
The revenue cannot currently be calculated for CardioComm Solutions.
The profit cannot currently be calculated for CardioComm Solutions.
The P/E ratio cannot be calculated for CardioComm Solutions at the moment.
The P/S cannot be calculated for CardioComm Solutions currently.
The Eulerpool Quality Score for CardioComm Solutions is 1/10.
The ISIN of CardioComm Solutions is CA14159N2086. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of CardioComm Solutions is A0M8Q9. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of CardioComm Solutions is EKG.V. The ticker symbol is used to trade CardioComm Solutions shares on the stock exchange.
CardioComm Solutions paid dividends every year for the past 0 years.
CardioComm Solutions is assigned to the 'Health' sector.
The dividends of CardioComm Solutions are distributed in CAD.
CardioComm Solutions stock
CardioComm Solutions Peer Group
CardioComm Solutions Ticker
CardioComm Solutions FIGI
All fundamentals and in-depth analysis of CardioComm Solutions
Our stock analysis for CardioComm Solutions stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CardioComm Solutions. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.